| Schwartz S
Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide. [JOURNAL ARTICLE]
Curr Med Res Opin 2008 Sep 30.
Abstract | Full Citation | | Tunis SL, Minshall ME, Charles MS, et al.
Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and dyslipidemia: cost-effectiveness in the US. [JOURNAL ARTICLE]
Curr Med Res Opin 2008 Sep 29.
Abstract | Full Citation | Find Related Articles | | Ye Y, Lin Y, Perez-Polo JR, et al.
Oral Glyburide, But Not Glimepiride, Blocks the Infarct-Size Limiting Effects of Pioglitazone. [JOURNAL ARTICLE]
Cardiovasc Drugs Ther 2008 Sep 30.
Abstract | Full Citation | | Pereira RI, Leitner JW, Erickson C, et al.
Pioglitazone acutely stimulates adiponectin secretion from mouse and human adipocytes via activation of the phosphatidylinositol 3'-kinase. [JOURNAL ARTICLE]
Life Sci 2008 Sep 16.
Abstract | Full Citation | | Hsiao PJ, Hsieh TJ, Kuo KK, et al.
Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet. [JOURNAL ARTICLE]
BMC Mol Biol 2008 Sep 26; 9(1):82.
Abstract | Full Citation | | Pitocco D, Giubilato S, Zaccardi F, et al.
Pioglitazone reduces monocyte activation in type 2 diabetes. [JOURNAL ARTICLE]
Acta Diabetol 2008 Sep 27.
Abstract | Full Citation | | Zhang WY, Schwartz EA, Permana PA, et al.
Pioglitazone Inhibits the Expression of Inflammatory Cytokines From Both Monocytes and Lymphocytes in Patients With Impaired Glucose Tolerance. [JOURNAL ARTICLE]
Arterioscler Thromb Vasc Biol 2008 Sep 25.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nakayama T, Komiyama N, Yokoyama M, et al.
Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: A randomized prospective study using intravascular ultrasound. [JOURNAL ARTICLE]
Int J Cardiol 2008 Sep 23.
Abstract | Full Citation | | Choi JS, Koh YY, Chung JH, et al.
Reduced prehepatic extraction of nicardipine in the presence of pioglitazone in rats. [Journal Article]
J Pharm Pharmacol 2008 Oct; 60(10):1403-7.
Abstract | Full Citation | Find Related Articles | | Aljada A, O'Connor L, Fu YY, et al.
PPARgamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis. [JOURNAL ARTICLE]
Angiogenesis 2008 Sep 23.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
